M. Lingohr-Smith

发表

Real-World Medical Cost Avoidance When New Oral Anticoagulants are Used Versus Warfarin for Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants

G. Fermann, Jay Lin, S. Deitelzweig, 2020, Journal of medical economics.

Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States

C. Russ, A. Nadkarni, O. Dina, 2018, Advances in Therapy.

Impact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States

E. Jabbour, Jay Lin, L. Siegartel, 2018, Leukemia & lymphoma.

Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US

T. Fan, Jay Lin, M. Lingohr-Smith, 2016, ClinicoEconomics and outcomes research : CEOR.

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA

B. Seal, Jay Lin, A. Aly, 2021, Hepatic oncology.

Improving quality of care in oncology through healthcare payment reform.

S. Ramsey, Jay Lin, M. Lingohr-Smith, 2018, The American journal of managed care.

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA

A. Amin, Jay Lin, M. Lingohr-Smith, 2019, Drugs in context.

Evaluating Costs of Biologic Drugs for the Treatment of Moderate-to-Severe Psoriasis in the United States

M. Lebwohl, S. Feldman, A. Armstrong, 2019, Journal of Psoriasis and Psoriatic Arthritis.

Estimated medical cost reductions for paliperidone palmitate vs placebo in a randomized, double-blind relapse-prevention trial of patients with schizoaffective disorder

K. Joshi, D. Fu, M. Lingohr-Smith, 2015, Journal of medical economics.

Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department

C. Russ, P. Hlavacek, Jay Lin, 2020, Hospital practice.

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States

A. Amin, J. Trocio, Jay Lin, 2015, Journal of managed care & specialty pharmacy.

Evaluation of medical costs associated with use of new oral anticoagulants compared with standard therapy among venous thromboembolism patients

A. Amin, J. Trocio, Jay Lin, 2014, Journal of medical economics.

Evaluation of medical costs avoided when new oral anticoagulants are used for extended treatment of venous thromboembolism based on clinical trial results

A. Amin, J. Trocio, Jay Lin, 2015, Journal of Thrombosis and Thrombolysis.

Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States

A. Nadkarni, P. Hlavacek, Jay Lin, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Impact of Genetic Mutations and Health Plan Access to Therapies on Treatment Response and Drug Costs Related to Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myelogenous Leukemia

E. Jabbour, Jay Lin, Dinara Makenbaeva, 2015, American journal of clinical oncology.

Venous Thromboembolism Prophylaxis and Risk for Acutely Medically Ill Patients Stratified by Different Ages and Renal Disease Status

A. Amin, Jay Lin, M. Lingohr-Smith, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Frequency of hospital readmissions for venous thromboembolism and associated hospital costs and length of stay among acute medically ill patients in the US

A. Amin, Jay Lin, S. Deitelzweig, 2019, Journal of medical economics.

Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis

A. Amin, Jay Lin, M. Lingohr-Smith, 2018, Advances in Therapy.

134

Jay Lin, S. Deitelzweig, M. Lingohr-Smith, 2018, Critical Care Medicine.

Use of Real-World Claim Databases to Assess Prevalence of Comorbid Conditions Relevant to the Treatment of Chronic Myelogenous Leukemia Based on National Comprehensive Network Treatment Guidelines.

E. Jabbour, Jay Lin, Dinara Makenbaeva, 2015, Clinical lymphoma, myeloma & leukemia.

Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US

Martin F Mendiola, E. Jabbour, Jay Lin, 2019, Journal of medical economics.

Economic value of regular monitoring of response to treatment among US patients with chronic myeloid leukemia based on an economic model

E. Jabbour, Jay Lin, L. Siegartel, 2018, Journal of medical economics.

Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA

G. Fermann, Jay Lin, S. Deitelzweig, 2020, Advances in Therapy.

Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA

C. Russ, Jay Lin, S. Deitelzweig, 2020, Journal of medical economics.

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

C. Russ, O. Dina, Jay Lin, 2019, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

C. Russ, O. Dina, Jay Lin, 2019, Current medical research and opinion.

All-Cause, Stroke/Systemic Embolism–, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants

J. Trocio, P. Hlavacek, Jay Lin, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Economic Evaluations of Medical Cost Differences: Use of Targeted-SpecificOral Anticoagulants vs. Warfarin among Patients with Nonvalvular AtrialFibrillation and Venous Thromboembolism in the U.S.

A. Amin, J. Trocio, Jay Lin, 2015 .

Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US

A. Amin, J. Trocio, Jay Lin, 2015, Journal of medical economics.

Real-World Adherence to Antiretroviral Therapy Among HIV-1 Patients Across the United States

G. McComsey, Jay Lin, R. Rogers, 2021, Advances in Therapy.

Comparison of the cost-effectiveness of biologic drugs used for moderate-to-severe psoriasis treatment in the United States

S. Feldman, Jashin J. Wu, Jay Lin, 2018, The Journal of dermatological treatment.

Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn’s Disease

M. Skup, J. Chao, R. Cross, 2018, Digestive Diseases and Sciences.

Effect of Apixaban Versus Warfarin Use on Health Care Resource Utilization and Costs Among Elderly Patients with Nonvalvular Atrial Fibrillation.

J. Trocio, Jay Lin, J. Mardekian, 2017, Journal of managed care & specialty pharmacy.

A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States.

S. Mathai, Jay Lin, E. Wang, 2017, Journal of managed care & specialty pharmacy.

Update on tolvaptan for the treatment of hyponatremia

J. Dasta, Jay Lin, J. Chiong, 2012, Expert review of pharmacoeconomics & outcomes research.

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States

E. Muser, Jay Lin, K. Joshi, 2016, Journal of clinical psychopharmacology.

COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies

Jay Lin, M. M. Moran, J. Judy, 2021, medRxiv.

Evaluation of healthcare resource utilization and incremental economic burden of patients with chronic myeloid leukemia after disease progression to blast phase

E. Jabbour, Jay Lin, L. Siegartel, 2017, Journal of medical economics.

Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors

Jay Lin, Dinara Makenbaeva, M. Lingohr-Smith, 2017, Journal of medical economics.

Frequency of Hospital Readmissions Post Allogeneic Hematopoietic Cell Transplantation

Jay Lin, E. Mozaffari, M. Lingohr-Smith, 2016 .

Hospitalizations and Mortality Associated with dsDNA Viral Infections Among Hematopoietic Cell Transplant Recipients

Jay Lin, E. Mozaffari, M. Lingohr-Smith, 2015 .

Comparison of readmissions among hospitalized nonvalvular atrial fibrillation patients treated with oral anticoagulants in the United States

C. Russ, O. Dina, Jay Lin, 2020, Journal of drug assessment.

Economic Burden of Treatment‐Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States

L. Alphs, J. Sheehan, Jay Lin, 2019, Psychiatric research and clinical practice.

The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans

S. Feldman, Jashin J. Wu, Jay Lin, 2018, Journal of medical economics.

February 2014

M. Bouvy, M. Kvasz, I. Milsom, 2014, Leonardo.

Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.

W. Kwong, M. Lingohr-Smith, J. Lin, 2014, Journal of managed care pharmacy : JMCP.

Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia

S. Chase, J. Dasta, Jay Lin, 2018, Hospital practice.

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

J. Trocio, A. Nadkarni, Jay Lin, 2017, Journal of medical economics.

Warfarin time in therapeutic range and its impact on healthcare resource utilization and costs among patients with nonvalvular atrial fibrillation

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Using Health Care Claims Data to Assess the Prevalence of Hodgkin Lymphoma and Relapsed or Refractory Hodgkin Lymphoma in the United States.

Jay Lin, L. Siegartel, Dinara Makenbaeva, 2017, Clinical therapeutics.

Impact of Warfarin Persistence on Health-Care Utilization and Costs Among Patients With Atrial Fibrillation Managed in Anticoagulation Clinics in the United States

J. Trocio, Jay Lin, S. Deitelzweig, 2018, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

An early evaluation of bleeding-related hospital readmissions among hospitalized patients with nonvalvular atrial fibrillation treated with direct oral anticoagulants

J. Trocio, Jay Lin, S. Deitelzweig, 2016, Current medical research and opinion.

Comparison of effectiveness and safety of treatment with apixaban vs. other oral anticoagulants among elderly nonvalvular atrial fibrillation patients

J. Trocio, Jay Lin, J. Mardekian, 2017, Current medical research and opinion.

Bacterial Vaginosis Treatment Patterns, Associated Complications, and Health Care Economic Burden of Women With Medicaid Coverage in the United States.

K. Tangirala, Jay Lin, K. Collins, 2023, The Annals of Pharmacotherapy.

Patient profiles, initial hospital encounter characteristics, and hospital re-encounters of patients with a hospital emergency department visit or inpatient admission for major depressive disorder

M. Mathews, Jay Lin, Qiaoyi Zhang, 2022, Journal of medical economics.

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

Jay Lin, S. Deitelzweig, M. Lingohr-Smith, 2017, Journal of medical economics.

Is Adherence to the American College of Chest Physicians Recommended Anticoagulation Treatment Duration Associated With Different Outcomes Among Patients With Venous Thromboembolism?

Jay Lin, R. Preblick, A. Spyropoulos, 2017, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Treatment patterns and economic burden of bacterial vaginosis among commercially insured women in the USA

M. Lingohr-Smith, Eren Watkins, Clifton M Chow, 2023, Journal of comparative effectiveness research.

Clinicoeconomics and Outcomes Research Dovepress Real-world Medication Persistence and Outcomes Associated with Basal Insulin and Glucagon-like Peptide 1 Receptor Agonist Free-dose Combination Therapy in Patients with Type 2 Diabetes in the Us

T. Fan, Jay Lin, M. Lingohr-Smith, 2022 .